CN Patent

CN109867695B — 一种匹伐他汀钙中间体的新制备方法

Assigned to Shanghai Jingxin Biological Medical Co ltd · Expires 2021-09-17 · 5y expired

What this patent protects

本发明涉及一种匹伐他汀钙中间体[[2‑环丙基‑4‑(4‑氟苯基)‑3‑喹啉基]甲基]三苯基溴化膦的制备方法，包括下述步骤：使2‑环丙基‑4‑(4‑氟苯基)‑3‑喹啉甲醇和三苯基膦氢溴酸盐在有机溶剂中进行反应，得到目标化合物。本发明的制备方法原料易得，操作简单，收率高，有效地减少了含磷废水和含磷废渣，降低了生产成本，有利于大规模生产。

USPTO Abstract

本发明涉及一种匹伐他汀钙中间体[[2‑环丙基‑4‑(4‑氟苯基)‑3‑喹啉基]甲基]三苯基溴化膦的制备方法，包括下述步骤：使2‑环丙基‑4‑(4‑氟苯基)‑3‑喹啉甲醇和三苯基膦氢溴酸盐在有机溶剂中进行反应，得到目标化合物。本发明的制备方法原料易得，操作简单，收率高，有效地减少了含磷废水和含磷废渣，降低了生产成本，有利于大规模生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN109867695B
Jurisdiction
CN
Classification
—
Expires
2021-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Jingxin Biological Medical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.